Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
837.70B
Market cap837.70B
Price-Earnings ratio
38.27
Price-Earnings ratio38.27
Dividend yield
0.71%
Dividend yield0.71%
Average volume
3.18M
Average volume3.18M
High today
$897.43
High today$897.43
Low today
$883.11
Low today$883.11
Open price
$888.47
Open price$888.47
Volume
3.07M
Volume3.07M
52 Week high
$1,133.95
52 Week high$1,133.95
52 Week low
$623.78
52 Week low$623.78

Stock Snapshot

The current Eli Lilly(LLY) stock price is $887.50, with a market capitalization of 837.7B. The stock trades at a price-to-earnings (P/E) ratio of 38.27 and offers a dividend yield of 70.9%.

As of 2026-03-31, Eli Lilly(LLY) stock has fluctuated between $883.11 and $897.43. The current price stands at $887.50, placing the stock +0.5% above today's low and -1.1% off the high.

Eli Lilly(LLY) shares are trading with a volume of 3.07M, against a daily average of 3.18M.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,133.95 at its peak.

LLY News

TipRanks 14h
Eli Lilly Stock Gets a Boost from Plan to Make Drugs Using AI

Shares of Eli Lilly (LLY) are marching higher after the pharmaceutical company announced plans to accelerate drug discoveries using artificial intelligence (AI)...

Nasdaq 14h
Eli Lilly's CEO Says This Could Be a Game Changer for Its Business

Key Points Eli Lilly believes that Medicare coverage for obesity drugs could be coming soon. The health benefits of GLP-1 drugs go beyond just weight loss. E...

Eli Lilly's CEO Says This Could Be a Game Changer for Its Business
Barron's 15h
Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. What It Means for the Stock.

Biotech and Pharma Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. What It Means for the Stock. In this article SPX DJIA PFE Eli Lilly struck a dea...

Eli Lilly Ramps Up AI Ambitions With This $2.8 Billion Deal. What It Means for the Stock.

Analyst ratings

83%

of 35 ratings
Buy
82.9%
Hold
14.3%
Sell
2.9%

More LLY News

TipRanks 17h
Eli Lilly price target lowered to $1,163 from $1,168 at Guggenheim

Guggenheim lowered the firm’s price target on Eli Lilly (LLY) to $1,163 from $1,168 and keeps a Buy rating on the shares after updating the firm’s model ahead o...

The Wall Street Journal 1d
Eli Lilly, InSilico Strike AI Drug Discovery Deal

The partnership is the latest in a string of tie-ups between pharma majors and Chinese companies. Bloomberg News Eli Lilly LLY -2.09 %decrease; red down pointi...

Eli Lilly, InSilico Strike AI Drug Discovery Deal
Benzinga 1d
Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report

Eli Lilly & Co. (NYSE:LLY) has reportedly finalized a $2.75 billion agreement to introduce AI-developed drugs from Hong Kong’s Insilico Medicine to the global m...

Eli Lilly Secures $2.75 Billion Deal With Insilico Medicine To Bring AI-Developed Drugs To Global Market: Report
Benzinga 1d
Eli Lilly Strikes $2.75B Deal To Bring AI-Developed Drugs Globally - Eli Lilly - benzinga.com

...

Eli Lilly Strikes $2.75B Deal To Bring AI-Developed Drugs Globally - Eli Lilly - benzinga.com
Nasdaq 2d
Insilico Medicine Strikes $2.75 Bln AI Drug Discovery Deal With Eli Lilly

(RTTNews) - InSilico Medicine Cayman TopCo (3696.HK) announced that it has entered into a licensing and drug discovery collaboration with Eli Lilly and Company...

Insilico Medicine Strikes $2.75 Bln AI Drug Discovery Deal With Eli Lilly
Seeking Alpha 2d
Eli Lilly expands AI drug push with multibillion-dollar Insilico deal

Eli Lilly (LLY) struck a new agreement with Insilico Medicine (ISLMF) that could be worth as much as $2.75 billion, deepening its investment in artificial intel...

Eli Lilly expands AI drug push with multibillion-dollar Insilico deal
Simply Wall St 2d
Eli Lilly PsA Trial Links Dual Therapy Success With Valuation Upside Potential

Eli Lilly (NYSE:LLY) reported Phase 3b TOGETHER-PsA data showing that Taltz combined with Zepbound outperformed Taltz alone in adults with both active psoriatic...

Eli Lilly PsA Trial Links Dual Therapy Success With Valuation Upside Potential

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.